272 related articles for article (PubMed ID: 21529984)
1. Klotho predicts good clinical outcome in patients with limited-disease small cell lung cancer who received surgery.
Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Saji H; Kakihana M; Kajiwara N; Uchida O; Nomura M; Ohira T; Ikeda N
Lung Cancer; 2011 Nov; 74(2):332-7. PubMed ID: 21529984
[TBL] [Abstract][Full Text] [Related]
2. Klotho is a novel biomarker for good survival in resected large cell neuroendocrine carcinoma of the lung.
Usuda J; Ichinose S; Ishizumi T; Ohtani K; Inoue T; Saji H; Kakihana M; Kajiwara N; Uchida O; Nomura M; Tsutsui H; Ohira T; Ikeda N
Lung Cancer; 2011 Jun; 72(3):355-9. PubMed ID: 21075474
[TBL] [Abstract][Full Text] [Related]
3. Surgical resection should be considered for stage I and II small cell carcinoma of the lung.
Weksler B; Nason KS; Shende M; Landreneau RJ; Pennathur A
Ann Thorac Surg; 2012 Sep; 94(3):889-93. PubMed ID: 22429675
[TBL] [Abstract][Full Text] [Related]
4. Survival outcomes with the use of surgery in limited-stage small cell lung cancer: should its role be re-evaluated?
Schreiber D; Rineer J; Weedon J; Vongtama D; Wortham A; Kim A; Han P; Choi K; Rotman M
Cancer; 2010 Mar; 116(5):1350-7. PubMed ID: 20082453
[TBL] [Abstract][Full Text] [Related]
5. Small cell lung cancer in Norway. Should more patients have been offered surgical therapy?
Rostad H; Naalsund A; Jacobsen R; Strand TE; Scott H; Heyerdahl Strøm E; Norstein J
Eur J Cardiothorac Surg; 2004 Oct; 26(4):782-6. PubMed ID: 15450573
[TBL] [Abstract][Full Text] [Related]
6. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
[TBL] [Abstract][Full Text] [Related]
7. Role of surgical resection for patients with limited disease-small cell lung cancer.
Takenaka T; Takenoyama M; Inamasu E; Yoshida T; Toyokawa G; Nosaki K; Hirai F; Yamaguchi M; Shimokawa M; Seto T; Ichinose Y
Lung Cancer; 2015 Apr; 88(1):52-6. PubMed ID: 25662387
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients with small cell lung carcinoma in Taiwan.
Kuo YH; Lin ZZ; Yang YY; Shao YY; Shau WY; Kuo RN; Yang JC; Lai MS
Oncology; 2012; 82(1):19-24. PubMed ID: 22269348
[TBL] [Abstract][Full Text] [Related]
9. [Relevance of surgery in small cell lung cancer].
Riquet M; Le Pimpec Barthes F; Scotté F; Fabre E; Cazes A; Foucault C; Danel C
Rev Pneumol Clin; 2009 Jun; 65(3):129-35. PubMed ID: 19524800
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come.
Brock MV; Hooker CM; Syphard JE; Westra W; Xu L; Alberg AJ; Mason D; Baylin SB; Herman JG; Yung RC; Brahmer J; Rudin CM; Ettinger DS; Yang SC
J Thorac Cardiovasc Surg; 2005 Jan; 129(1):64-72. PubMed ID: 15632826
[TBL] [Abstract][Full Text] [Related]
11. The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period.
Hansen O; Sørensen P; Hansen KH
Lung Cancer; 2010 Apr; 68(1):111-4. PubMed ID: 19535164
[TBL] [Abstract][Full Text] [Related]
12. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
13. Should aggressive surgery ever be part of the management of small cell lung cancer?
Waddell TK; Shepherd FA
Thorac Surg Clin; 2004 May; 14(2):271-81. PubMed ID: 15382303
[TBL] [Abstract][Full Text] [Related]
14. Lobectomy leads to optimal survival in early-stage small cell lung cancer: a retrospective analysis.
Varlotto JM; Recht A; Flickinger JC; Medford-Davis LN; Dyer AM; DeCamp MM
J Thorac Cardiovasc Surg; 2011 Sep; 142(3):538-46. PubMed ID: 21684554
[TBL] [Abstract][Full Text] [Related]
15. Is neoadjuvant chemotherapy mandatory for limited-disease small-cell lung cancer?
Xu YJ; Zheng H; Gao W; Jiang GN; Xie HK; Chen C; Fei K
Interact Cardiovasc Thorac Surg; 2014 Dec; 19(6):887-93. PubMed ID: 25156899
[TBL] [Abstract][Full Text] [Related]
16. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
Lu L; Katsaros D; Wiley A; de la Longrais IA; Puopolo M; Yu H
Cancer Invest; 2008 Mar; 26(2):185-92. PubMed ID: 18259951
[TBL] [Abstract][Full Text] [Related]
17. [Clinical analysis of surgical treatment for 86 patients with localized small-cell lung cancer].
Fu Q; Gai X; Ji Z
Zhonghua Zhong Liu Za Zhi; 1996 Sep; 18(5):382-4. PubMed ID: 9387282
[TBL] [Abstract][Full Text] [Related]
18. [Combined modality therapy for small cell lung cancer patient with limited stage disease].
Wang HJ; Sun KL; Zhang XR; Sun Y; Shi YK
Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):701-3. PubMed ID: 18246803
[TBL] [Abstract][Full Text] [Related]
19. A retrospective comparative study of surgery followed by chemotherapy vs. non-surgical management in limited-disease small cell lung cancer.
Badzio A; Kurowski K; Karnicka-Mlodkowska H; Jassem J
Eur J Cardiothorac Surg; 2004 Jul; 26(1):183-8. PubMed ID: 15200999
[TBL] [Abstract][Full Text] [Related]
20. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer.
Kawasaki M; Nakanishi Y; Kuwano K; Yatsunami J; Takayama K; Hara N
Clin Cancer Res; 1997 Jul; 3(7):1195-200. PubMed ID: 9815799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]